APA (7th ed.) Citation

I, B., R, C., R, B., L, M., E, C., C, O., . . . V, N. (2020). Duration of antibiotic therapy in critically ill patients: A randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers. Critical care (London, England), 24(1), 281. https://doi.org/10.1186/s13054-020-02946-y

Chicago Style (17th ed.) Citation

I, Borges, et al. "Duration of Antibiotic Therapy in Critically Ill Patients: A Randomized Controlled Trial of a Clinical and C-reactive Protein-based Protocol Versus an Evidence-based Best Practice Strategy Without Biomarkers." Critical Care (London, England) 24, no. 1 (2020): 281. https://doi.org/10.1186/s13054-020-02946-y.

MLA (9th ed.) Citation

I, Borges, et al. "Duration of Antibiotic Therapy in Critically Ill Patients: A Randomized Controlled Trial of a Clinical and C-reactive Protein-based Protocol Versus an Evidence-based Best Practice Strategy Without Biomarkers." Critical Care (London, England), vol. 24, no. 1, 2020, p. 281, https://doi.org/10.1186/s13054-020-02946-y.